Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GRANULES INDIA vs SUVEN PHARMACEUTICALS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GRANULES INDIA SUVEN PHARMACEUTICALS GRANULES INDIA/
SUVEN PHARMACEUTICALS
 
P/E (TTM) x 26.4 46.4 56.8% View Chart
P/BV x 3.7 9.9 37.3% View Chart
Dividend Yield % 0.3 0.9 39.3%  

Financials

 GRANULES INDIA   SUVEN PHARMACEUTICALS
EQUITY SHARE DATA
    GRANULES INDIA
Mar-23
SUVEN PHARMACEUTICALS
Mar-23
GRANULES INDIA/
SUVEN PHARMACEUTICALS
5-Yr Chart
Click to enlarge
High Rs381629 60.6%   
Low Rs227388 58.6%   
Sales per share (Unadj.) Rs186.452.7 354.1%  
Earnings per share (Unadj.) Rs21.316.2 132.1%  
Cash flow per share (Unadj.) Rs29.018.0 160.6%  
Dividends per share (Unadj.) Rs1.506.00 25.0%  
Avg Dividend yield %0.51.2 41.8%  
Book value per share (Unadj.) Rs116.468.2 170.7%  
Shares outstanding (eoy) m242.04254.57 95.1%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.69.7 16.9%   
Avg P/E ratio x14.231.5 45.3%  
P/CF ratio (eoy) x10.528.2 37.2%  
Price / Book Value ratio x2.67.5 35.0%  
Dividend payout %7.037.1 18.9%   
Avg Mkt Cap Rs m73,611129,395 56.9%   
No. of employees `000NANA-   
Total wages/salary Rs m4,2031,105 380.4%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m45,11913,403 336.6%  
Other income Rs m143464 30.8%   
Total revenues Rs m45,26213,867 326.4%   
Gross profit Rs m9,1335,739 159.1%  
Depreciation Rs m1,845477 386.5%   
Interest Rs m559128 436.6%   
Profit before tax Rs m6,8725,597 122.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,7061,484 114.9%   
Profit after tax Rs m5,1664,113 125.6%  
Gross profit margin %20.242.8 47.3%  
Effective tax rate %24.826.5 93.6%   
Net profit margin %11.430.7 37.3%  
BALANCE SHEET DATA
Current assets Rs m25,74111,554 222.8%   
Current liabilities Rs m18,1353,031 598.3%   
Net working cap to sales %16.963.6 26.5%  
Current ratio x1.43.8 37.2%  
Inventory Days Days14148 9.7%  
Debtors Days Days77302 25.4%  
Net fixed assets Rs m23,2909,547 244.0%   
Share capital Rs m242255 95.1%   
"Free" reserves Rs m27,92717,097 163.3%   
Net worth Rs m28,16917,352 162.3%   
Long term debt Rs m1,48646 3,256.9%   
Total assets Rs m49,03121,101 232.4%  
Interest coverage x13.344.7 29.7%   
Debt to equity ratio x0.10 2,006.2%  
Sales to assets ratio x0.90.6 144.9%   
Return on assets %11.720.1 58.1%  
Return on equity %18.323.7 77.4%  
Return on capital %25.132.9 76.1%  
Exports to sales %81.00-   
Imports to sales %31.30-   
Exports (fob) Rs m36,526NA-   
Imports (cif) Rs m14,120NA-   
Fx inflow Rs m36,52614,672 249.0%   
Fx outflow Rs m14,1201,848 764.2%   
Net fx Rs m22,40612,824 174.7%   
CASH FLOW
From Operations Rs m7,3874,509 163.8%  
From Investments Rs m-1,914-1,948 98.2%  
From Financial Activity Rs m-4,403-2,358 186.7%  
Net Cashflow Rs m1,068202 527.9%  

Share Holding

Indian Promoters % 41.6 9.9 420.3%  
Foreign collaborators % 0.4 50.1 0.7%  
Indian inst/Mut Fund % 28.9 26.1 110.9%  
FIIs % 18.8 10.1 185.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 58.0 40.0 145.1%  
Shareholders   190,691 70,052 272.2%  
Pledged promoter(s) holding % 4.1 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GRANULES INDIA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on GRANULES INDIA vs SUVEN PHARMACEUTICALS

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

GRANULES INDIA vs SUVEN PHARMACEUTICALS Share Price Performance

Period GRANULES INDIA SUVEN PHARMACEUTICALS S&P BSE HEALTHCARE
1-Day 0.03% 5.78% 1.18%
1-Month -6.51% 5.21% -0.75%
1-Year 58.65% 44.00% 61.82%
3-Year CAGR 11.62% 12.19% 18.16%
5-Year CAGR 29.84% 32.13% 19.79%

* Compound Annual Growth Rate

Here are more details on the GRANULES INDIA share price and the SUVEN PHARMACEUTICALS share price.

Moving on to shareholding structures...

The promoters of GRANULES INDIA hold a 42.0% stake in the company. In case of SUVEN PHARMACEUTICALS the stake stands at 60.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of GRANULES INDIA and the shareholding pattern of SUVEN PHARMACEUTICALS.

Finally, a word on dividends...

In the most recent financial year, GRANULES INDIA paid a dividend of Rs 1.5 per share. This amounted to a Dividend Payout ratio of 7.0%.

SUVEN PHARMACEUTICALS paid Rs 6.0, and its dividend payout ratio stood at 37.1%.

You may visit here to review the dividend history of GRANULES INDIA, and the dividend history of SUVEN PHARMACEUTICALS.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.